Questions Answered on ART Safety and Tolerability in Pregnant People and Transgender Individuals

CCO Infectious Disease Podcast

In this episode, Jill Blumenthal, MD, MAS, and William R. Short, MD, MPH, AAHIVS, address key considerations when evaluating ART safety and tolerability in pregnant people, those trying to conceive, and transgender individuals, such as:

• Approaching patients trying to conceive on nonpreferred ART regimens (eg, 2-drug regimens like LA CAB and RPV)
• Optimizing the use of the Antiretroviral Pregnancy Registry
• Addressing unique barriers to ARV adherence in transgender individuals with HIV (eg, drug formulation considerations for ARV medications and gender-affirming hormone therapy, sperm banking or egg harvesting, drug coverage considerations)

Faculty:
Jill Blumenthal, MD, MAS
Associate Professor of Medicine
Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California

William R. Short, MD, MPH, AAHIVS
Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Link to full program:
http://bit.ly/3PM3nYe

Link to downloadable slides:
http://bit.ly/3WgYycz